Rapid Micro Biosystems (RPID) Return on Equity (2021 - 2026)

Rapid Micro Biosystems' Return on Equity history runs 6 years deep, the most recent figure standing at 0.02% for Q1 2026.

• In Q1 2026, Return on Equity fell 1.0% year-over-year to 0.02%; the TTM figure through Mar 2026 stood at 0.02% (down 1.0% YoY), while the FY2025 annual figure was 0.01%, changed 0.0% from the prior year.
• Return on Equity came in at 0.02% for Q1 2026 at Rapid Micro Biosystems, down from 0.01% in the prior quarter.
• In the past five years, Return on Equity ranged from a high of 0.0% in Q1 2022 to a low of 0.02% in Q1 2026.
• A 5-year average of 0.01% and a median of 0.0% in 2024 frame the typical range for Return on Equity.
• On a YoY basis, Return on Equity climbed as much as 2 bps in 2022 and fell as far as 1 bps in 2022.
• Rapid Micro Biosystems' Return on Equity stood at 0.0% in 2022, then decreased by 20 bps to 0.0% in 2023, then tumbled by 38 bps to 0.01% in 2024, then plunged by 107 bps to 0.01% in 2025, then slumped by 54 bps to 0.02% in 2026.
• According to Business Quant data, Return on Equity over the past three periods registered 0.02%, 0.01%, and 0.01% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison